Published in Cancer Weekly, February 13th, 2001
J.A. Vilpo and colleagues at Tampere University conducted a study to measure the "cytotoxicity of vincristine in vitro...in B chronic lymphocytic leukemia (CLL) cells and in normal peripheral blood mononuclear cells." The results of their research were published in the European Journal of Haematology.
They found that vincristine was roughly 25 times more likely to attack leukemic cells than normal monocytes. Sensitivity to the alkaloid was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.